Abbot Financial Management, Inc. Eli Lilly & CO Call Options Transaction History

Abbot Financial Management, Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $345,072 - $446,712	-2,100 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $160,842 - $186,043	1,100 Added 110.0%	2,100 $311,000
Q2 2020 Jul 22, 2020	SELL	$136.42 - $164.18 $27,283 - $32,836	-200 Reduced 16.67%	1,000 $165,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 7.69%	1,200 $167,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $138,996 - $172,159	1,300 New	1,300 $171,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Abbot Financial Management, Inc. with notifications on news.